Rochester, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and […]
PALO ALTO, Calif.– Origin Technologies Corporation, LLC (“Origin”), a newly created entity owned by a group of former Affymetrix executives for the purpose of privatizing Affymetrix, Inc. (“Affymetrix”, NASDAQ: AFFX), today issued the following statement: “We are committed to completing a friendly transaction with Affymetrix and reiterate our offer to acquire all of the company’s […]
WALTHAM, Mass.– Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today commented on the press release of Affymetrix, Inc. that responded to the unsolicited, non-binding proposal received on March 18, 2016, from Origin Technologies Corporation, LLC (the “Origin Proposal”). Thermo Fisher agrees with Affymetrix and its board of directors that the Origin Proposal […]
SANTA CLARA, Calif. – Affymetrix Inc. (NASDAQ: AFFX) Affymetrix announced that it has reviewed the proposal made by Origin Technologies Corporation, LLC (“Origin”) on March 18 for a transaction in which the stockholders of Affymetrix would receive $16.10 per share in cash. In reviewing the proposal, the Board of Directors notes that Origin appears to […]
PALO ALTO, Calif. – Origin Technologies Corporation, LLC (“Origin”), a newly created entity owned by a group of former Affymetrix executives announced that it submitted a proposal to acquire Affymetrix, Inc. (“Affymetrix”) for $16.10 per share in an all-cash transaction valued at approximately $1.5 billion. This proposal represents a 75% premium to Affymetrix’ unaffected closing […]
HOLLISTON, Mass., – Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, received a notice from NASDAQ (the “Notice”) stating the Company is not in compliance with Listing Rule 5250(c)(1) for continued listing because it has not yet filed its Annual Report […]
PLEASANTON, Calif. – 10x Genomics, a company focused on improving and broadening the application of genomic information announced the close of a $55 million Series C financing. The financing round was led by Fidelity Management & Research Company and included additional new investors Softbank and JS Capital Management LLC, alongside founding investors Venrock, Foresite Capital, […]
Agilent Technologies Inc. (NYSE: A) announced that a quarterly dividend of 11.5 cents per share of common stock will be paid on April 27, 2016, to all shareholders of record as of the close of business on April 5, 2016. The timing and amounts of future dividends are subject to determination and approval by Agilent’s […]
With a growth of 17% and a turnover of 269 million EUR in 2015, FOSS achieved the best sales results ever. The result is due to a number of clients in particular in Europe, the US and China, who have invested in more efficient food production using FOSS’ analytical solutions. FOSS changes CEO in 2016 […]
Cambridge, UK – Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
